A six-year retrospective review of concomitant HIV and mycobacterial infection in the Republic of Ireland is presented. A total of 42 culture proven mycobacterial infections were seen in 40 different HIV-infected patients. There were 24 infections with Mycobacterium tuberculosis (M.tb) and 18 infections with mycobacteria other than tuberculosis (MOTT), a significantly higher rate of MOTT infections in Ireland compared to a study from 1962–1981. The detection rate for all mycobacterial infections had an annual upward trend with a 4-fold increase between 1987 and 1992. In homosexuals, MOTT infections occurred more frequently than M.tb, while the reverse was true for IVDUs. Twenty per cent of the infections were seen in patients recently incarcerated. Relapse of tuberculosis occurred in 42.9% (3/7) of non-compliant patients, 2 of whom developed rifampin-resistant strains of M.tb. No patient compliant to their regimen had a relapse in disease. The overall survival of patients after diagnosis of M.tb was significantly better than those with MOTT infections, with respective one-year survival rate of 79% and 36% (log rank test, P=0.006).
American Thoracic Society. Treatment of tuberculosis and other mycobacterial diseases. November 1982.
2.
SunderamGMcDonaldRJMarnitisTOleskaJKapilaRReichmanLB.Tuberculosis as a manifestation of the acquired immunodeficiency syndrome. JAMA1986;256:362–6.
3.
PitchenikAERubinsonHA.The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis1965;13:393–6.
4.
Centers for Disease Control. Diagnosis and management of mycobacterial infection and disease in persons with human immunodeficiency virus infection. Ann Intern Med1987;106:254–6.
5.
SelwynPAHartelDLewisVAA prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med1989;320:545–50.
6.
SmallPMSchecterGFGoodmanPCSanderMAChaissonREHopewellPC.Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med1991;324:289–94.
7.
HorsburghCR.Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med1991;324:1332–7.
8.
BarnesPFBlackABDavidsonPTSniderDE.Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med1991;324:1644–50.
9.
PerroneCGhoubontniALepontCSalmon-CeranDBricaireFVildeJL.Should pulmonary tuberculosis be an AIDS-defining diagnosis in patients infected with HIV?Tubercle Lung Dis1992;73:39–44.
10.
Center for Disease Control. Revision of the case definition of acquired immune deficiency syndrome. MMWR1987;36(IS):15–155.
11.
Center for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR1992;41(RR 17):1–19.
12.
HealyEKellyPMulcahyFMClancyL.AIDS, IV drug use and mycobacterial disease: The Dublin experience. Respir Med1992;86:491–4.
13.
KellyPMurphyAClancyL.Mycobacterium tuberculosis hominis infection and AIDS. Ir Med J1987;80:271.
14.
CollinsCKellyPByrneCDenhamFClancyL.Is bovine, atypical or resistent tuberculosis a problem?Ir Med J1987;80:66–7.
15.
DaleyCLSmallPMSchecterGFAn outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N Engl J Med1992;326:231–5.
16.
HowellF.The epidemiology of tuberculosis in a geographically defined area. Ir J Med Sci1992, (Abstract 0.20).
17.
StinsonJKellyPHowellFClancyL.National Tuberculosis Survey. Ir Med J1988;88:7–10.
18.
HowellFKellyPClancyL.Pulmonary tuberculosis in the Republic of Ireland: An epidemiological profile from a single unit. Respir Med1990;84:111–7.
19.
HowellFO'LaoideRKellyPPowerLClancyL.Short course chemotherapy for pulmonary tuberculosis: A randomized controlled trial of a six month versus a nine month oral regimen. Ir Med J1989;82:11–3.
20.
LevineBChaissonRE.Mycobacterium kansasii: A cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection. Ann Intern Med1991;114:861–8.
21.
MurphyMGaffneyKCareyODooleyIMulcahyF.The impact of HIV disease on an Irish prison population. Int J STD AIDS1992;3:426–9.
22.
HorsburghCRSelikRM.The epidemiology of disseminated non-tuberculous mycobacterial infection in the acquired immunodeficiency syndrome. Am Rev Respir Dis1989;139:4–7.
23.
KellyPWRedfieldRRWardDLLurkeDSMullenRN.Prevalence and incidence of HTLV-3 in a prison. JAMA1986;256:2190–9.
24.
GaughainMDDouglasRMLewisCDaviesLMylvagananATreffkeHEdwardsJAloR.HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS1991;5:845–51.
25.
HarnettT.1989 Update. Aids in correctional facilities. Washington DC: National Institute of Justice, US Department of Justice, 1990.
26.
HorsburghCJarvisTMcArthurTIgnacioTStackP.Seroconversion to human immunodeficiency virus in prison inmates. Am J Public Health1990;80:209–10.
27.
TomasevskiK.AIDS and Prisons. AIDS1991;5:S245–51.
28.
RomanusV.Experience in Sweden 15 years after stopping general BCG vaccination at birth. Bull IUATLD1990;65:30–7.
29.
TrnkaLDankovaDMachovaASvandovaFHajdovaE.Project on discontinuation of BCG vaccination in newborns in Czechoslovakia. Bull IUATLD1990;65:30–7.
30.
HorganJMDalyLO'BoyleM.Ir J Med Sci1988;157:252–5.
31.
TomlinsonDRMossFMcCartyMMitchellDMainJHarrisJRWKarimQN.Tuberculosis in HIV seropositive individuals—A Retrospective Analysis. Int J STD AIDS1992:3:38–41.
32.
MaherJKellyPHughesPClancyL.Skin anergy and tuberculosis. Respir Med1992;86:481–4.
33.
National action plan to combat multidrug-resistant tuberculosis. MMWR1992;41(RR 11).
34.
BloomBRMurrayCJL.Tuberculosis: Commentary on a reemergent killer. Science1992;257:1055–64.
35.
BachettiPOsmondDChaissonRESurvival patterns of the first 500 patients with AIDS San Francisco. J Infect Dis1988;157:1044–7.
36.
RothenbergRWoelfelMStonebunnerRMilbergJPankerRTrumanB.Survival with the Acquired Immuno-deficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med1987;317:1297–302.
37.
BatalleJGatellJMCaylaJAPlasenciaAJaniaMJParelladaN.Predictors of the survival of AIDS cases in Barcelona, Spain. AIDS1989;3:353–9.
38.
BindelsPJPoosRMJJongJTMulderJWJagerHTCCoutinhoRA.Trends in mortality among AIDS patients in Amsterdam, 1982–1988. AIDS1991;5:853–8.
39.
MossARBachettiP.Natural history of HIV infection. AIDS1989;3:55–61.
40.
MontellaFDi SoraFRecchiaORobertoAPreitePA.The natural history of the HIV infection in HIV-seropositive intravenous drug users (IVDUs). Seventh International Conference on AIDS. Florence 1991 (ABSTRACT W.C.3354, vol 2).
41.
JordiTMugaRTudelaPSabriaMFozM.AIDS incidence in intravenous drug users from a general hospital of Barcelona. Eighth International Conference on AIDS/3rd STD World Congress, Amsterdam 1992 (ABSTRACT PuC8228, vol 2).
